Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Divers J, Núñez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI.

Kidney Int. 2013 Dec;84(6):1207-13. doi: 10.1038/ki.2013.173. Epub 2013 May 15.

2.

The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR.

J Am Soc Nephrol. 2010 Sep;21(9):1422-6. doi: 10.1681/ASN.2010070730. Epub 2010 Aug 5. Review.

3.

APOL1 and nephropathy progression in populations of African ancestry.

Freedman BI.

Semin Nephrol. 2013 Sep;33(5):425-32. doi: 10.1016/j.semnephrol.2013.07.004. Review.

4.

Target organ damage in African American hypertension: role of APOL1.

Freedman BI, Murea M.

Curr Hypertens Rep. 2012 Feb;14(1):21-8. doi: 10.1007/s11906-011-0237-4. Review.

5.

APOL1 and kidney disease.

Pollak MR, Genovese G, Friedman DJ.

Curr Opin Nephrol Hypertens. 2012 Mar;21(2):179-82. doi: 10.1097/MNH.0b013e32835012ab. Review.

PMID:
22257798
6.

JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases.

Kantarci G, Eren Z, Demirağ A, Dogan I, Cakalagaoglu F, Yilmaz G.

Transpl Infect Dis. 2011 Feb;13(1):89-92. doi: 10.1111/j.1399-3062.2010.00567.x. Epub 2010 Sep 6. Review.

PMID:
21299772
7.

Population genetics of chronic kidney disease: the evolving story of APOL1.

Wasser WG, Tzur S, Wolday D, Adu D, Baumstein D, Rosset S, Skorecki K.

J Nephrol. 2012 Sep-Oct;25(5):603-18. doi: 10.5301/jn.5000179. Review.

PMID:
22878977
8.

Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Freedman BI, Skorecki K.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5. Review.

9.

APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, Kopp JB.

Semin Nephrol. 2015 May;35(3):222-36. doi: 10.1016/j.semnephrol.2015.04.008. Review.

10.

APOL1 kidney risk alleles: population genetics and disease associations.

Limou S, Nelson GW, Kopp JB, Winkler CA.

Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005. Review.

11.

APOL1 toxin, innate immunity, and kidney injury.

Limou S, Dummer PD, Nelson GW, Kopp JB, Winkler CA.

Kidney Int. 2015 Jul;88(1):28-34. doi: 10.1038/ki.2015.109. Epub 2015 Apr 8. Review.

12.

The spectrum of MYH9-associated nephropathy.

Bostrom MA, Freedman BI.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1107-13. doi: 10.2215/CJN.08721209. Epub 2010 Mar 18. Review.

13.

APOL1 nephropathy: from gene to mechanisms of kidney injury.

Kruzel-Davila E, Wasser WG, Aviram S, Skorecki K.

Nephrol Dial Transplant. 2016 Mar;31(3):349-58. doi: 10.1093/ndt/gfu391. Epub 2015 Jan 5. Review.

PMID:
25561578
14.

Advances in the pathogenesis of HIV-associated kidney diseases.

Ross MJ.

Kidney Int. 2014 Aug;86(2):266-74. doi: 10.1038/ki.2014.167. Epub 2014 May 14. Review.

PMID:
24827777
15.

Apolipoprotein L1 and Kidney Disease in African Americans.

Friedman DJ, Pollak MR.

Trends Endocrinol Metab. 2016 Apr;27(4):204-15. doi: 10.1016/j.tem.2016.02.002. Epub 2016 Mar 3. Review.

PMID:
26947522
16.

Hypertension-attributed nephropathy: what's in a name?

Freedman BI, Cohen AH.

Nat Rev Nephrol. 2016 Jan;12(1):27-36. doi: 10.1038/nrneph.2015.172. Epub 2015 Nov 10. Review.

PMID:
26553514
Items per page

Supplemental Content

Write to the Help Desk